Mitchell S. Analyst PerformanceBiotech Analyst at HC WainwrightMitchell S. is a stock analyst at HC Wainwright focused in the medical sector, covering 29 publicly traded companies. Over the past year, Mitchell S. has issued 118 stock ratings, including buy, hold, and sell recommendations. While full access to Mitchell S.'s proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mitchell S.'s coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings118 Last 0 YearsBuy Recommendations86.44% 102 Buy RatingsCompanies Covered29 Unique Companies Ratings Distribution118RatingsDistribution of strong buy, buy, hold, and sell ratings by Mitchell S..RatingPercentageCount Strong Buy0.0%0 ratings Buy86.4%102 ratings Hold9.3%11 ratings Sell4.2%5 ratingsOut of 118 total stock ratings issued by Mitchell S. at HC Wainwright, the majority (86.4%) have been Buy recommendations, followed by 9.3% Hold and 4.2% Sell.Best & Worst CallsThis analyst does not have any ratings with enough history to determine best and worst calls.Exchange CoverageExchangePercentageCountNASDAQ96.6% of companies on NASDAQ28 companiesNYSE3.4% of companies on NYSE1 companyMitchell S., an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical27 companies93.1%Manufacturing2 companies6.9%Mitchell S. of HC Wainwright specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE17 companies58.6%MED - DRUGS9 companies31.0%Miscellaneous2 companies6.9%PHARMACEUTICAL PREPARATIONS1 company3.4% Mitchell S.'s Ratings History at HC Wainwright Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsORKAOruka Therapeutics6/3/2026Reiterated Rating$55.23Buy$0.0000.00% ROIKYTXKyverna Therapeutics6/3/2026Reiterated Rating$7.86$25.00Buy$0.0000.00% ROILEGNLegend Biotech6/3/2026Boost Price Target$36.28$65.00Buy$0.0000.00% ROILYELLyell Immunopharma6/3/2026Reiterated Rating$14.89$45.00Buy$0.0000.00% ROILEGNLegend Biotech5/27/2026Reiterated Rating$29.53Buy$0.0000.00% ROIIONSIonis Pharmaceuticals5/27/2026Reiterated Rating$76.07$125.00Buy$0.0000.00% ROIEVMNEvommune5/26/2026Reiterated Rating$22.74$50.00Buy$0.0000.00% ROISMMTSummit Therapeutics5/22/2026Downgrade$17.47Neutral$0.0000.00% ROIINCYIncyte5/21/2026Reiterated Rating$97.08$135.00Buy$0.0000.00% ROIKRROKorro Bio5/19/2026Lower Price Target$9.97$15.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. LEGNLegend Biotech5/18/2026Reiterated Rating$27.55$50.00Buy$0.0000.00% ROIORKAOruka Therapeutics5/18/2026Reiterated Rating$61.93$120.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/18/2026Lower Price Target$50.63$50.00Neutral$0.0000.00% ROIALMSAlumis5/15/2026Downgrade$24.63$25.00Neutral$0.0000.00% ROIKYTXKyverna Therapeutics5/15/2026Boost Price Target$10.74$25.00Buy$0.0000.00% ROITYRATyra Biosciences5/14/2026Reiterated Rating$36.18$45.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics5/14/2026Lower Price Target$19.85$35.00Buy$0.0000.00% ROINTLAIntellia Therapeutics5/13/2026Lower Price Target$13.99$25.00Buy$0.0000.00% ROIRNACCartesian Therapeutics5/12/2026Lower Price Target$8.53$25.00Buy$0.0000.00% ROICTMXCytomX Therapeutics5/11/2026Lower Price Target$3.98$11.00Buy$0.0000.00% ROIGENBGenerate Biomedicines5/8/2026Boost Price Target$13.59$25.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical5/5/2026Reiterated Rating$55.46$55.00Neutral$0.0000.00% ROIINCYIncyte5/4/2026Reiterated Rating$96.91$135.00Buy$0.0000.00% ROISMMTSummit Therapeutics5/4/2026Lower Price Target$16.11$23.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals4/30/2026Boost Price Target$74.83$125.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/29/2026Boost Price Target$73.99$120.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics4/29/2026Boost Price Target$63.86$95.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics4/23/2026Reiterated Rating$10.23$20.00Buy$0.0000.00% ROILEGNLegend Biotech4/21/2026Reiterated Rating$25.07$50.00Buy$0.0000.00% ROISRPTSarepta Therapeutics4/16/2026Reiterated Rating$21.07Sell$0.0000.00% ROILEGNLegend Biotech4/15/2026Reiterated Rating$18.69$50.00Buy$0.0000.00% ROIINCYIncyte4/15/2026Reiterated Rating$97.69$135.00Buy$0.0000.00% ROIORKAOruka Therapeutics4/13/2026Boost Price Target$59.58$70.00Buy$0.0000.00% ROIGENBGenerate Biomedicines4/13/2026Initiated Coverage$11.41$16.00Buy$0.0000.00% ROIALMSAlumis3/30/2026Lower Price Target$24.80$25.00Buy$0.0000.00% ROIPALIPalisade Bio3/26/2026Initiated Coverage$2.00$7.00Buy$0.0000.00% ROIINCYIncyte3/25/2026Reiterated Rating$90.62$135.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics3/25/2026Boost Price Target$13.45$40.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals3/25/2026Boost Price Target$73.05$120.00Buy$0.0000.00% ROIEVMNEvommune3/18/2026Lower Price Target$24.99$50.00Buy$0.0000.00% ROITrump's gold order: the announcement they won't put on the front page (Ad)On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.Request the free guide in 30 seconds and get positioned nowCTMXCytomX Therapeutics3/16/2026Boost Price Target$7.81$17.00Buy$0.0000.00% ROIINCYIncyte3/9/2026Reiterated Rating$95.94$135.00Buy$0.0000.00% ROINTLAIntellia Therapeutics3/3/2026Boost Price Target$15.44$30.00Buy$0.0000.00% ROISRPTSarepta Therapeutics3/2/2026Reiterated Rating$16.76Sell$0.0000.00% ROICBIOCrescent Biopharma3/2/2026Lower Price Target$12.09$22.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/25/2026Lower Price Target$62.62$55.00Neutral$0.0000.00% ROISMMTSummit Therapeutics2/24/2026Lower Price Target$16.09$30.00Buy$0.0000.00% ROITYRATyra Biosciences2/17/2026Boost Price Target$27.99$45.00Buy$0.0000.00% ROIINCYIncyte2/11/2026Reiterated Rating$100.05$135.00Buy$0.0000.00% ROIEVMNEvommune2/10/2026Boost Price Target$25.02$65.00Buy$0.0000.00% ROISMMTSummit Therapeutics2/2/2026Reiterated Rating$14.48$40.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics1/29/2026Reiterated Rating$71.70Buy$0.0000.00% ROINTLAIntellia Therapeutics1/28/2026Boost Price Target$14.83$25.00Buy$0.0000.00% ROISRPTSarepta Therapeutics1/27/2026Reiterated Rating$22.80Sell$0.0000.00% ROILEGNLegend Biotech1/22/2026Lower Price Target$20.76$50.00Buy$0.0000.00% ROIAVTXAvalo Therapeutics1/15/2026Reiterated Rating$16.19$25.00Buy$0.0000.00% ROISMMTSummit Therapeutics1/14/2026Reiterated Rating$16.81Buy$0.0000.00% ROISRPTSarepta Therapeutics1/14/2026Reiterated Rating$21.46Sell$0.0000.00% ROILXEOLexeo Therapeutics1/13/2026Lower Price Target$8.12$10.00Buy$0.0000.00% ROINGNENeurogene1/13/2026Reiterated Rating$17.28$70.00Buy$0.0000.00% ROIALMSAlumis1/9/2026Reiterated Rating$18.18$40.00Buy$0.0000.00% ROITILInstil Bio1/7/2026Reiterated Rating$7.03Neutral$0.0000.00% ROIBMRNBioMarin Pharmaceutical12/22/2025Boost Price Target$61.15$60.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics12/19/2025Reiterated Rating$65.11$90.00Buy$0.0000.00% ROIALMSAlumis12/18/2025Boost Price Target$11.03$20.00Buy$0.0000.00% ROILYELLyell Immunopharma12/9/2025Upgrade$28.36$45.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics11/28/2025Reiterated Rating$72.66$90.00Buy$0.0000.00% ROILEGNLegend Biotech11/26/2025Reiterated Rating$28.19Buy$0.0000.00% ROIRNACCartesian Therapeutics11/19/2025Lower Price Target$7.62$30.00Buy$0.0000.00% ROINGNENeurogene11/13/2025Boost Price Target$31.08$70.00Buy$0.0000.00% ROIKRROKorro Bio11/13/2025Reiterated Rating$31.42Neutral$0.0000.00% ROICTMXCytomX Therapeutics11/11/2025Boost Price Target$4.19$10.00Buy$0.0000.00% ROINTLAIntellia Therapeutics11/10/2025Lower Price Target$9.52$15.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals11/10/2025Boost Price Target$73.55$110.00Buy$0.0000.00% ROILXEOLexeo Therapeutics11/3/2025Reiterated Rating$9.01Buy$0.0000.00% ROINGNENeurogene10/31/2025Boost Price Target$33.14$65.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/30/2025Boost Price Target$73.46$100.00Buy$0.0000.00% ROINTLAIntellia Therapeutics10/27/2025Lower Price Target$14.48$25.00Buy$0.0000.00% ROIORKAOruka Therapeutics10/27/2025Lower Price Target$27.25$40.00Buy$0.0000.00% ROIKYTXKyverna Therapeutics10/27/2025Boost Price Target$7.44$20.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/27/2025Lower Price Target$52.67$55.00Neutral$0.0000.00% ROIHALOHalozyme Therapeutics10/21/2025Reiterated Rating$66.47Buy$0.0000.00% ROISMMTSummit Therapeutics10/21/2025Lower Price Target$20.03$40.00Buy$0.0000.00% ROILXEOLexeo Therapeutics10/21/2025Lower Price Target$9.22$13.00Buy$0.0000.00% ROILEGNLegend Biotech10/17/2025Lower Price Target$32.36$60.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/15/2025Reiterated Rating$66.65$90.00Buy$0.0000.00% ROINGNENeurogene10/9/2025Reiterated Rating$28.20$45.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals10/8/2025Reiterated Rating$68.94$95.00Buy$0.0000.00% ROILXEOLexeo Therapeutics10/7/2025Boost Price Target$8.42$15.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics10/2/2025Boost Price Target$74.94$90.00Buy$0.0000.00% ROISkip the Line Opportunity: The SpaceX IPO (Ad)Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their historic runs - says the SpaceX IPO is set for June 12 and could be the most anticipated market debut ever. Brown is showing investors how to legally claim a stake before the company goes public, ahead of what chief market strategist Shay Boloor called 'the craziest IPO in the history of the stock market.'Click here to see how to position in SpaceX before June 12CRSPCRISPR Therapeutics9/23/2025Reiterated Rating$62.10$80.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/23/2025Reiterated Rating$61.36$95.00Buy$0.0000.00% ROIHALOHalozyme Therapeutics9/22/2025Boost Price Target$77.81$85.00Buy$0.0000.00% ROINTLAIntellia Therapeutics9/19/2025Boost Price Target$16.11$30.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/16/2025Reiterated Rating$18.94$50.00Buy$0.0000.00% ROITILInstil Bio9/11/2025Reiterated Rating$24.16$125.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/8/2025Reiterated Rating$25.98$50.00Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical9/8/2025Initiated Coverage$57.77$60.00Neutral$0.0000.00% ROIEDITEditas Medicine9/5/2025Reiterated Rating$2.52$5.00Buy$0.0000.00% ROISMMTSummit Therapeutics9/2/2025Reiterated Rating$23.70$50.00Buy$0.0000.00% ROIIONSIonis Pharmaceuticals9/2/2025Boost Price Target$42.63$95.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/27/2025Boost Price Target$26.98$50.00Buy$0.0000.00% ROICBIOCrescent Biopharma8/27/2025Reiterated Rating$14.47$25.00Buy$0.0000.00% ROITILInstil Bio8/27/2025Reiterated Rating$28.41$125.00Buy$0.0000.00% ROISRPTSarepta Therapeutics8/25/2025Reiterated Rating$20.22Sell$0.0000.00% ROIIONSIonis Pharmaceuticals8/22/2025Boost Price Target$43.24$70.00Buy$0.0000.00% ROITYRATyra Biosciences8/22/2025Reiterated Rating$11.70$30.00Buy$0.0000.00% ROIMGXMetagenomi8/19/2025Reiterated Rating$1.92$7.00Buy$0.0000.00% ROIZURAZura Bio8/19/2025Lower Price Target$1.74$2.00Neutral$0.0000.00% ROIORKAOruka Therapeutics8/18/2025Reiterated Rating$15.37$45.00Buy$0.0000.00% ROILXEOLexeo Therapeutics8/15/2025Lower Price Target$4.79$9.00Buy$0.0000.00% ROITILInstil Bio8/15/2025Reiterated Rating$28.25$125.00Buy$0.0000.00% ROISMMTSummit Therapeutics8/15/2025Reiterated Rating$26.45$44.00Buy$0.0000.00% ROIALMSAlumis8/14/2025Reiterated Rating$4.42$14.00Buy$0.0000.00% ROIKRROKorro Bio8/13/2025Lower Price Target$15.99$90.00Buy$0.0000.00% ROICBIOCrescent Biopharma8/11/2025Initiated Coverage$12.85$25.00Buy$0.0000.00% ROIBOLDBoundless Bio8/11/2025Lower Price Target$1.10$4.00Buy$0.0000.00% ROINTLAIntellia Therapeutics8/8/2025Lower Price Target$11.46$25.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
